We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Rapid Malaria Diagnostic Test Evaluated in Asia

By LabMedica International staff writers
Posted on 03 Jan 2013
Rapid diagnostic tests (RDT) for malaria have been brought into field operations to supplement and in some cases replace the gold standard of light microscopy. More...


Although attempts have been made to augment or even replace microscopic diagnosis of malaria with enzyme-linked immunosorbent assays (ELISA), real time, and conventional polymerase chain reactions (PCR), these are not feasible in the field.

Scientists at the International Centre for Diarrhoeal Disease Research, Bangladesh (ICDDR,B; Dhaka, Bangladesh) collected whole blood samples from 372 febrile patients referred for malaria diagnosis by clinicians from May 2009 to December 2010. The samples were assayed by a newly available RDT and were compared to microscopy adjusted with nested PCR as the gold standard. DNA extraction for the PCR was prepared using QiaAmp blood mini-kit (Qiagen; Hilden, Germany) from preserved whole blood. Other PCR reagents were obtained from New England BioLabs Inc.; Ipswich, MA, USA).

The RDT device evaluated was the Onsite (Pf/Pan) RDT produced by CTK Biotech Inc. (San Diego, CA, USA) which has the ability to detect Pan-specific lactate dehydrogenase (pLDH) and Plasmodium falciparum specific histidine-rich protein 2 (HRP-2). Of these 372 patients, 229 (61.6%) tested positive for malaria infection detected by microscopy and nested PCR. The OnSite (Pf/Pan) RDT was 94.2% sensitive and 99.5% specific for P. falciparum diagnosis and 97.3% sensitive and 98.7% specific for P. vivax diagnosis. Sensitivity varied with differential parasite count for both malaria species. The highest sensitivity was observed in febrile patients with parasitemias that ranged from 501 to 1,000 parasites/µL regardless of the Plasmodium species.

The authors concluded that the OnSite (Pf/Pan) RDT, a lateral flow chromatographic immunoassay, performed satisfactorily in standard laboratory conditions. It can be utilized for diagnosis of symptomatic malaria as well as to discriminate falciparum malaria infection from vivax malaria in endemic areas and during outbreaks. However, a field evaluation is required to assess its applicability for routine diagnosis in resource-limited settings where the practicability of microscopy is limited. The study was published on December 12, 2012, in the Malaria Journal.

Related Links:
International Centre for Diarrheal Disease Research Bangladesh
Qiagen
New England BioLabs Inc.




Gold Member
Ketosis and DKA Test
D-3-Hydroxybutyrate (Ranbut) Assay
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Automated Chemiluminescence Immunoassay Analyzer
MS-i3080
Gold Member
Immunochromatographic Assay
CRYPTO Cassette
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: Residual leukemia cells may predict long-term survival in acute myeloid leukemia (Photo courtesy of Shutterstock)

MRD Tests Could Predict Survival in Leukemia Patients

Acute myeloid leukemia is an aggressive blood cancer that disrupts normal blood cell production and often relapses even after intensive treatment. Clinicians currently lack early, reliable markers to predict... Read more

Pathology

view channel
Image: The AI tool advances precision diagnostics by linking genetic mutations directly to disease types (Photo courtesy of Shutterstock)

AI Tool Simultaneously Identifies Genetic Mutations and Disease Type

Interpreting genetic test results remains a major challenge in modern medicine, particularly for rare and complex diseases. While existing tools can indicate whether a genetic mutation is harmful, they... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.